Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extracellular proteolysis and angiogenesis.

M S Pepper1

  • 1Department of Morphology, University Medical Center, Geneva, Switzerland. michael.pepper@medecine.unige.ch

Thrombosis and Haemostasis
|August 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A national survey of therapeutic facilities for managing hypoxic ischaemic encephalopathy in tertiary neonatal wards in South African public hospitals.

SAJCH : the South African journal of child health·2026
Same author

Bayesian inference of haematopoietic stem/progenitor cell differentiation phenotypic manifolds and their bifurcation points using Gaussian processes and Gibbs sampling.

Scientific reports·2026
Same author

Translational human and equine regenerative medicine in musculoskeletal conditions.

Journal of equine veterinary science·2026
Same author

Right of reply - Response to: In defence of South Africa's National Health Research Ethics Council guidelines on heritable human genome editing.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Addressing the limitations of the regulatory landscape in South Africa regarding advanced cell and gene therapies and related sectors involving human cells, tissues and organs.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025
Same author

Progress in advanced cellular and gene therapies in South Africa and barriers to patient access: A National Consortium paper on behalf of the BloodSA Cell and Gene Therapy working party.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025

Extracellular proteolysis is essential for new blood vessel formation (angiogenesis). Targeting proteolysis offers therapeutic strategies for diseases involving excessive blood vessel growth.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Extracellular proteolysis is crucial for angiogenesis, the formation of new blood vessels.
  • Matrix metalloproteinases and plasminogen activator/plasmin systems are key players in this process.
  • Angioregulatory molecules like angiostatin and endostatin are generated via extracellular proteolysis.

Purpose of the Study:

  • To review the roles of matrix metalloproteinases and plasminogen activator/plasmin systems in angiogenesis.
  • To discuss the generation and bioactivity of angioregulatory molecules.
  • To highlight the therapeutic potential of targeting proteolysis in neovascularization-related diseases.

Main Methods:

  • Literature review of existing research on extracellular proteolysis and angiogenesis.

Related Experiment Videos

  • Analysis of the molecular mechanisms underlying the generation of angioregulatory factors.
  • Examination of therapeutic strategies targeting anti-proteolysis in angiogenesis.

    • Main Results:

    • Extracellular proteolysis is indispensable for angiogenesis.
    • Specific proteolytic systems, including matrix metalloproteinases and plasminogen activators, are integral to blood vessel formation.
    • The precise molecular mechanisms of angioregulatory molecules like angiostatin and endostatin remain to be elucidated.
    • Anti-proteolysis strategies are being developed to inhibit pathological neovascularization.

    Conclusions:

    • Extracellular proteolysis is a fundamental process in angiogenesis.
    • Understanding these proteolytic systems and their regulatory molecules is vital for therapeutic development.
    • Targeting proteolysis represents a promising approach for treating diseases characterized by aberrant angiogenesis.